Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q2 2025 Earnings Call Transcript August 7, 2025
Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $1.6, expectations were $1.54.
Operator: Good day, and welcome to the Ligand Second Quarter 2025 Earnings Call. [Operator Instructions] And finally, I would like to advise all participants that this call is being recorded. Thank you. I’d now like to welcome Melanie Herman, Executive Director of Investor Relations,...
